Stock Mumak

Stock Profile

Micron

Micron benefits from AI, HBM, and strong growth. Our analysis highlights fundamentals, valuation, analysts, and technical analysis.

Stock Snapshot

Micron Technology_Logo
Table HeaderTable Header
CompanyMicron Technology, Inc.
SectorTechnology
ThemeArtificial intelligence, data centers & advanced semiconductors
Business ModelGlobal semiconductor manufacturer focused on memory and storage solutions, including DRAM, NAND, and NOR products for data centers, AI infrastructure, PCs, smartphones, automotive, and industrial applications.
ISINUS5951121038
Market Capitalizationapprox. USD 1,130 billion
UMBRELLA StatusActive
  • Geopolitics
  • Industry
  • Fundamentals
  • Sentiment
  • Technical Analysis

Price Performance (12 Months)

Aktuelle Unternehmensmeldungen

Micron
Technology

Valuation Analysis: Micron Technology

ISIN: US5951121038

Micron is evolving from a traditional memory chip manufacturer into a key player in AI infrastructure. HBM, data center demand, and strong financial results are driving growth. Our valuation analysis examines geopolitics, the industry, fundamentals, analyst sentiment, and technical analysis—highlighting which opportunities and risks are now decisive.
Compass 5 out of 5
Active icon
More research

Latest Portfolio Updates

Revolution Medicines
Company Update

European Defense Stocks Under Pressure: How the UMBRELLA Strategy Reacts

European defense stocks are coming under pressure. How does the UMBRELLA Strategy react to weaker momentum, high valuations, and the
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: Micron Technology – AI memory in focus

Micron Technology is benefiting from strong demand for AI memory. Fundamentals, the industry backdrop, and technicals are providing positive tailwinds.
Next Update
Weekly Update

Weekly Market Overview – August 31-September 6, 2026

UMBRELLA strategy: Focus continues to shift toward healthcare and advanced technologies
Next Update
MUMAK SpotLight

MUMAK SpotLight of the week: Eli Lilly and Palantir in focus

Eli Lilly strengthens its pipeline, Palantir remains volatile, and Johnson & Johnson gains momentum. The most important developments of the
Next Update